EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From basic science to clinical case application
This second edition EHA-SWG Scientific Meeting will examine the red cell and iron biology in relation to the erythropoietic differentiation process. Human beings produce billions of red cells on a daily basis. We would like to examine this machinery and underline the mechanisms that allow this enormous cell production in order to better understand the alterations responsible for red blood cell disorders.
This meeting will offer attendees the opportunity to improve their understanding of the learning protocols for differential diagnosis and treatment of different types of anemias, from clinical observation.
Below you can find key information and links to important details regarding registration and accommodation. There is also a wide array of sponsorship opportunities available for pharmaceutical companies.
EHA Topics-in-Focus Hemoglobinopathies
This meeting is part of the Topics-in-Focus (TIF) program on Hemoglobinopathies, launched by the EHA Board at EHA23. This program is aimed at raising awareness, providing education, furthering research, and building a network of experts with the ultimate goal to improve patient care.
Hematologists, pediatricians, biomedical scientists, biologists and general practitioners.
The program will examine all the possibilities regarding diagnosis and treatment of both inherited and acquired conditions of anemias. The meeting will start with an introductory lecture discussing the general molecular physiology of erythropoiesis and iron homeostasis and the rest of the meeting will focus on clinical cases based for the different conditions, with interactive discussion.
This meeting will cover the following topics:
- Sickle cell disease
- Diserythropoietic anemias
- Red cell enzyme defects
- Atypical microcytic anemias
- Hereditary hemochromatosis
- Iron metabolism
The full program can be found here.